Davide Gianni

4.0k citations

59 papers · 2.6k indexed · h-index 27

Impact in

Genetics top 2%
- Virus-based gene therapy research
Immunology top 5%
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms

Papers in

Aging 2
Physiology 14
- Alzheimer's disease research and treatments 7
- Nitric Oxide and Endothelin Effects 6

Co-authors: Gary Bokoch Nicolas Taulet Céline DerMardirossian Sara A. Courtneidge E. Antonio Chiocca Giulia Fulci Miguel Sena‐Esteves Ralph Weissleder
Journals: SLAS DISCOVERY (6 papers)Cancer Research (4 papers)Journal of Biological Chemistry (3 papers)Molecular Therapy (3 papers)Cell Reports (2 papers)
Partner nations: United States United Kingdom Italy

In The Last Decade

Davide Gianni

55 papers receiving 2.6k citations

Peers

Countries citing papers authored by Davide Gianni

Since Specialization

Citations

This map shows the geographic impact of Davide Gianni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davide Gianni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davide Gianni more than expected).

Fields of papers citing papers by Davide Gianni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Davide Gianni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davide Gianni. The network helps show where Davide Gianni may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Davide Gianni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Davide Gianni Line = papers co-authored together Davide Gianni links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The limitations of small molecule and genetic screening in phenotypic drug discovery Cell chemical biology ·Fabien Vincent, Davide Gianni	2025	0
2	146 (PB134): First disclosure of AZD3470, a highly potent MTA-cooperative PRMT5 inhibitor in PRIMROSE and PRIMAVERA clinical studies European Journal of Cancer ·Julian R. Smith, Jelena Urosevic, S. Breanndan Moore, Łukasz Magiera, Lisa Bradshaw, Davide Gianni, Bharath Srinivasan, J.E. Debreczeni, C. W. Stubbs, Mercedes Vázquez–Chantada, Tao Hong, Anna Cronin, Karim Khan, Eve J. Wiseman, Douglas Ferguson, James T. Lynch, Hing Man Chan, R.N. Makhwathana, Stephen E. Fawell, Emma Dean	2024	0
3	A multi-parametric high throughput assay for detecting beta-cell proliferation in dispersed primary islets SLAS DISCOVERY ·N Mullooly, David M. Smith, Davide Gianni	2023	2
4	Highly scalable arrayed CRISPR mediated gene silencing in primary lung small airway epithelial cells SLAS DISCOVERY ·Tracy Bevington, N Mullooly, Alessia Serrano, 直美鶴谷, Ceri M. Wiggins, Davide Gianni	2023	0
5	Selecting the right therapeutic target for kidney disease Frontiers in Pharmacology ·Lisa Buvall, Robert Menzies, Julie Williams, Kevin Woollard, Chanchal Kumar, Anna Granqvist, Maria Fritsch, A. W. Wenigerkind, Anna Reznichenko, Davide Gianni, Slavé Petrovski, Claus Bendtsen, Mohammad Bohlooly‐Y, Carolina Haefliger, Regina Fritsche Danielson, Pernille Hansen	2022	8
6	CRISPR gRNA phenotypic screening in zebrafish reveals pro-regenerative genes in spinal cord injury PLoS Genetics ·Marcus Keatinge, Themistoklis M. Tsarouchas, Meagan Oglesby, C L Trempe, Neri van Laar, Davide Gianni, Hui‐Hsin Tsai, Catherina G. Becker, David A. Lyons, Thomas Becker	2021	42
7	CGRP, adrenomedullin and adrenomedullin 2 display endogenous GPCR agonist bias in primary human cardiovascular cells Communications Biology ·فاطمه اربابی کلاتی, N Mullooly, 清美猪瀬, Matthew Harris, Tessa de Vries, Antoinette MaassenVanDenBrink, David R. Poyner, Davide Gianni, Mark Wigglesworth, Graham Ladds	2021	25
8	Arrayed CRISPR Screening Identifies Novel Targets That Enhance the Productive Delivery of mRNA by MC3-Based Lipid Nanoparticles SLAS DISCOVERY ·Douglas Ross‐Thriepland, Aurélie Bornot, Bhugendra Chutia, Arpan S. Desai, Himjyot Jaiswal, S Peel, Morag R. Hunter, Bin Liu, Beverley Isherwood, Davide Gianni	2020	18
9	Positioning High-Throughput CETSA in Early Drug Discovery through Screening against B-Raf and PARP1 SLAS DISCOVERY ·Joseph Shaw, Ian L. Dale, Paul Hemsley, Lindsey Leach, Coreen Loke, Jonathan P. Orme, 王浩明, A.J. Narvaez, Michał Biśta, Daniel Martinez Molina, Michael Dabrowski, Martin J. Main, Davide Gianni	2018	31
10	Determining direct binders of the Androgen Receptor using a high-throughput Cellular Thermal Shift Assay Scientific Reports ·Joseph Shaw, Е. Ф. Прозоров, Maria Juniwati, Ascolese A, Daniel Martinez Molina, Daniel O’Neill, James J. Dowling, Paul R. J. Davey, Faisal Akbar Saenal, Michael Dabrowski, Martin J. Main, Davide Gianni	2018	47
11	Stanniocalcin1 is a key mediator of amyloidogenic light chain induced cardiotoxicity Basic Research in Cardiology ·Jian Guan, Shikha Mishra, Jianru Shi, Eva Plovie, Yiling Qiu, Xin Cao, Davide Gianni, Bingbing Jiang, Federica del Monte, Lawreen H. Connors, David C. Seldin, Francesca Lavatelli, Paola Rognoni, Giovanni Palladini, Giampaolo Merlini, Rodney H. Falk, Marc J. Semigran, G. William Dec, Calum A. MacRae, Ronglih Liao	2013	55
12	Induced Pluripotent Stem Cell Models of Progranulin-Deficient Frontotemporal Dementia Uncover Specific Reversible Neuronal Defects Cell Reports ·Sandra Almeida, Zhijun Zhang, Giangennaro Coppola, Wenjie Mao, Kensuke Futai, Anna Karydas, Michael D. Geschwind, Maria Carmela Tartaglia, Fuying Gao, Davide Gianni, Miguel Sena‐Esteves, Daniel H. Geschwind, Bruce L. Miller, Robert V. Farese, Fen‐Biao Gao	2012	3
13	Regression of Schwannomas Induced by Adeno-Associated Virus-Mediated Delivery of Caspase-1 Human Gene Therapy ·Shilpa Prabhakar, Shantanu Barai, Davide Gianni, Thomas J. Conlon, Giulia Fulci, Joar Røkke Fystro, Anat Stemmer‐Rachamimov, Miguel Sena‐Esteves, Xandra O. Breakefield, Gary J. Brenner	2012	23
14	Targeting HSV-1 virions for specific binding to epidermal growth factor receptor-vIII-bearing tumor cells Cancer Gene Therapy ·Paola Grandi, J Fernández, P Ferenc, Richard Carter, Davide Gianni, Miguel Sena‐Esteves, Xandra O. Breakefield	2010	19
15	Physiological Transgene Regulation and Functional Complementation of a Neurological Disease Gene Deficiency in Neurons Molecular Therapy ·Pier Paolo Peruzzi, Sean Lawler, Steven L. Senior, Nina Dmitrieva, Pauline Edser, Davide Gianni, E. Antonio Chiocca, Richard Wade‐Martins	2009	15
16	Identification of a Conserved Rac-binding Site on NADPH Oxidases Supports a Direct GTPase Regulatory Mechanism Journal of Biological Chemistry ·Shijie Mao, Davide Gianni, Benjamin P. Bohl, R. M. Taylor, Gary Bokoch	2008	56
17	Depletion of Peripheral Macrophages and Brain Microglia Increases Brain Tumor Titers of Oncolytic Viruses Cancer Research ·Giulia Fulci, Nina Dmitrieva, Davide Gianni, 殷守革, Xiaogang Pan, Brenda L. Coomber, Claire Kaufman, Balveen Kaur, Sean Lawler, Robert J. Lee, Clay B. Marsh, Daniel J. Brat, Nico van Rooijen, Koen Debeule, Fred H. Hochberg, Ralph Weissleder, Robert L. Martuza, E. Antonio Chiocca	2007	135
18	X-ray powder diffraction characterization of disilver trihydrogen paraperiodate Powder Diffraction ·Norberto Masciocchi, Davide Gianni	2006	1
19	Cyclophosphamide Increases Transgene Expression Mediated by an Oncolytic Adenovirus in Glioma-Bearing Mice Monitored by Bioluminescence Imaging Molecular Therapy ·Martine L.M. Lamfers, Giulia Fulci, Davide Gianni, Yi Tang, Kazuhiko Kurozumi, Balveen Kaur, J. M. Kemp, Yoshinaga Saeki, Jan E. Carette, Ralph Weissleder, W. Peter Vandertop, Victor W. van Beusechem, Clemens M.F. Dirven, E. Antonio Chiocca	2006	72
20	SERCA2a in Heart Failure: Role and Therapeutic Prospects Journal of Bioenergetics and Biomembranes ·Davide Gianni, A. E. Vandenbon, Judith K. Gwathmey, Federica del Monte, Roger J. Hajjar	2005	48

About Davide Gianni

Davide Gianni is a scholar working on Aging, Physiology, Molecular Biology, Immunology and Allergy and Genetics, having authored 59 papers that have together received 2.6k indexed citations. Recurring topics across this work include Virus-based gene therapy research (9 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (8 papers), CRISPR and Genetic Engineering (7 papers), Alzheimer's disease research and treatments (7 papers), Nitric Oxide and Endothelin Effects (6 papers), RNA Interference and Gene Delivery (6 papers), CAR-T cell therapy research (6 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). The work is most often cited by research in Genetics (717 citations), Immunology (485 citations), Molecular Biology (1.5k citations), Physiology (555 citations) and Neurology (155 citations). Davide Gianni has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Gary Bokoch, Nicolas Taulet, Céline DerMardirossian, Sara A. Courtneidge, E. Antonio Chiocca, Giulia Fulci, Miguel Sena‐Esteves, Ralph Weissleder, Balveen Kaur and Federica del Monte. Their work appears in journals such as SLAS DISCOVERY, Cancer Research, Journal of Biological Chemistry, Molecular Therapy and Cell Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact